Ginkgo Bioworks Holdings Inc., a leader in cell programming and biosecurity, has been awarded a $4.66 million contract to deliver an advanced automated anaerobic phenotyping platform to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Laboratory. This system, based on Ginkgo's Reconfigurable Automation Cart $(RAC)$ technology, will consist of an integrated workcell with 18 devices housed within a modular anaerobic chamber. The platform will enable EMSL scientists to conduct complex end-to-end anaerobic phenotyping workflows remotely, enhancing research efficiency and accelerating discoveries in microbial engineering and bioeconomy science. This collaboration aims to strengthen U.S. leadership in biotechnology and bioeconomy research.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。